RxDoctor Payments Data

Michael Anderson, DO

Foot and Ankle Surgery · Woodbury, MNNPI 1437446887

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (32.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Arthrex at 56.8% of the total.

$9,066in general payments, 2019–2025

Across 72 payments — averaging $125.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Stryker$2K
  • Foundation Medical, LLC$1K
  • Paragon 28, Inc.$377
  • Johnson & Johnson$342
  • Gemini Medical LLC$188
  • plus $223 from 3 others

What the payments were for

  • Speaking & faculty fees$2,00022%
  • Travel & lodging$2,90732%
  • Food & beverage$2,68130%
  • Education$1,47816%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex28$5,147
Stryker19$1,707
Foundation Medical, LLC4$1,083
Paragon 28, Inc.5$377
Johnson & Johnson7$342
Gemini Medical LLC3$188
Gemini Mountain Medical, LLC1$124
Orthofix Medical, Inc.4$73
AbbVie1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,066 in reported general payments places this provider in the 75th percentile of 102 foot and ankle surgery providers in Minnesota.

See all foot and ankle surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$72,635
Medicare patients
226
Services billed
1,916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyzine Hcl49$341
Oxycodone Hcl95$313
Meloxicam16$39

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Woodbury

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →